Abstract
Generating a pharmacophore is often the first step towards understanding the interactions between a receptor and a ligand and can be pivotal to a successful drug discovery project. The pharmacophore tools at Accelrys have been used to assist in many different projects over the years, such as lead generation, scaffold hopping, mining ligand databases as well as many more. In this article, we will review the pharmacophore tools that have been developed at Accelrys. These will include the often used and well validated ligand based algorithms, HipHop and HypoGen and as well as extensions of these algorithms, HipHopRefine and HypoGenRefine. Recently we also developed new pharmacophore tools in the area of structure based design – deriving pharmacophores from the receptor as well as the receptor-ligand complex – which will also be discussed in this paper.
Keywords: Fragment-based design, receptor-ligand pharmacophore, structure-based pharmacophore, scaffold hopping, mining ligand databases, algorithms, pharmacophore tools, structure based design, receptor-ligand complex, 2D SAR
Current Computer-Aided Drug Design
Title: New Features that Improve the Pharmacophore Tools from Accelrys
Volume: 7 Issue: 3
Author(s): Jon Sutter, Jiabo Li, Allister J. Maynard, Anne Goupil, Tien Luu and Katalin Nadassy
Affiliation:
Keywords: Fragment-based design, receptor-ligand pharmacophore, structure-based pharmacophore, scaffold hopping, mining ligand databases, algorithms, pharmacophore tools, structure based design, receptor-ligand complex, 2D SAR
Abstract: Generating a pharmacophore is often the first step towards understanding the interactions between a receptor and a ligand and can be pivotal to a successful drug discovery project. The pharmacophore tools at Accelrys have been used to assist in many different projects over the years, such as lead generation, scaffold hopping, mining ligand databases as well as many more. In this article, we will review the pharmacophore tools that have been developed at Accelrys. These will include the often used and well validated ligand based algorithms, HipHop and HypoGen and as well as extensions of these algorithms, HipHopRefine and HypoGenRefine. Recently we also developed new pharmacophore tools in the area of structure based design – deriving pharmacophores from the receptor as well as the receptor-ligand complex – which will also be discussed in this paper.
Export Options
About this article
Cite this article as:
Sutter Jon, Li Jiabo, J. Maynard Allister, Goupil Anne, Luu Tien and Nadassy Katalin, New Features that Improve the Pharmacophore Tools from Accelrys, Current Computer-Aided Drug Design 2011; 7 (3) . https://dx.doi.org/10.2174/157340911796504305
DOI https://dx.doi.org/10.2174/157340911796504305 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Role of Neopterin in Atherogenesis and Cardiovascular Risk Assessment
Current Medicinal Chemistry Current Progress in Antifibroitcs
Current Medicinal Chemistry Antagonists of CCR4 as Immunomodulatory Agents
Current Topics in Medicinal Chemistry Cancer Gene Therapy by Adenovirus-Mediated Gene Transfer
Current Gene Therapy Lipid Lowering Drugs and Gallstones: A Therapeutic Option?
Current Pharmaceutical Design Restoration of the Immune Balance by Autologous Bone Marrow Transplantation in Juvenile Idiopathic Arthritis
Current Stem Cell Research & Therapy Role of the Endocannabinoid System in the Neuroendocrine Responses to Inflammation
Current Pharmaceutical Design The Use of Naltrexone in Dermatology. Current Evidence and Future Directions
Current Drug Targets Targeting Pathways Mediating Bone Disease
Current Pharmaceutical Biotechnology CoMFA and CoMSIA Analyses of Highly Selective Pipecolic Acid Based TNF-α Converting Enzyme (TACE) Inhibitors Using Docked Conformations for Molecular Alignment
Letters in Drug Design & Discovery Differential Innate Immune Responses to Low or High Dose Oral SIV Challenge in Rhesus Macaques
Current HIV Research Antibody-Based Targeted Interventions for the Diagnosis and Treatment of Skin Cancers
Anti-Cancer Agents in Medicinal Chemistry Patient Attitudes Toward Western Medicine and the Future of Chinese Medicine for Spondyloarthritis
Current Rheumatology Reviews Maintaining Plasma Fibrinogen Levels and Fibrinogen Replacement Therapies for Treatment of Intracranial Hemorrhage
Current Drug Targets Cytokines Polymorphism and mRNA Expression as Biomarkers in HCV Treatment Response
Recent Patents on Biomarkers Isolation and Quantitative Methods for Analysis of Non-Steroidal Anti-Inflammatory Drugs
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Editorial [Hot Topic: Inhibition of the Renin-Angiotensin-Aldosterone System: How to Obtain This (Executive Guest Editors: Aldo Pende and Fabrizio Montecucco )]
Current Pharmaceutical Design Targeting Heat Shock Proteins 70/90 and Proteasome for Cancer Therapy
Current Medicinal Chemistry Apoptosis Signaling Pathways as Therapeutic Targets in Lung Injury
Letters in Drug Design & Discovery Immunopathology of Rheumatoid Arthritis
Current Topics in Medicinal Chemistry